| Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial ZW Peng, YJ Zhang, MS Chen, L Xu, HH Liang, XJ Lin, RP Guo, ... Journal of clinical oncology 31 (4), 426-432, 2013 | 601 | 2013 |
| Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH) Z Peng, W Fan, B Zhu, G Wang, J Sun, C Xiao, F Huang, R Tang, ... Journal of Clinical Oncology 41 (1), 117-127, 2023 | 337 | 2023 |
| Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study ZW Peng, XJ Lin, YJ Zhang, HH Liang, RP Guo, M Shi, MS Chen Radiology 262 (3), 1022-1033, 2012 | 304 | 2012 |
| Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal N Ikenaga, ZW Peng, KA Vaid, SB Liu, S Yoshida, DY Sverdlov, ... Gut 66 (9), 1697-1708, 2017 | 286 | 2017 |
| Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial ZW Peng, YJ Zhang, HH Liang, XJ Lin, RP Guo, MS Chen Radiology 262 (2), 689-700, 2012 | 261 | 2012 |
| Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice SB Liu, N Ikenaga, ZW Peng, DY Sverdlov, A Greenstein, V Smith, ... The FASEB Journal 30 (4), 1599-1609, 2016 | 239 | 2016 |
| Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI ST Feng, Y Jia, B Liao, B Huang, Q Zhou, X Li, K Wei, L Chen, B Li, ... European radiology 29, 4648-4659, 2019 | 195 | 2019 |
| Tumor-on-a-chip: from bioinspired design to biomedical application X Liu, J Fang, S Huang, X Wu, X Xie, J Wang, F Liu, M Zhang, Z Peng, ... Microsystems & Nanoengineering 7 (1), 50, 2021 | 187 | 2021 |
| Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus ZW Peng, RP Guo, YJ Zhang, XJ Lin, MS Chen, WY Lau Cancer 118 (19), 4725-4736, 2012 | 184 | 2012 |
| Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study HH Liang, MS Chen, ZW Peng, YJ Zhang, YQ Zhang, JQ Li, WY Lau Annals of surgical oncology 15, 3484-3493, 2008 | 174 | 2008 |
| Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma H Peng, Q Zhang, J Li, N Zhang, Y Hua, L Xu, Y Deng, J Lai, Z Peng, ... Oncotarget 7 (13), 17220, 2016 | 159 | 2016 |
| Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice S Yoshida, N Ikenaga, SB Liu, ZW Peng, J Chung, DY Sverdlov, ... Gastroenterology 147 (6), 1378-1392, 2014 | 157 | 2014 |
| Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation J Dan, Y Zhang, Z Peng, J Huang, H Gao, L Xu, M Chen PloS one 8 (3), e58184, 2013 | 145 | 2013 |
| Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis ZW Peng, N Ikenaga, SB Liu, DY Sverdlov, KA Vaid, R Dixit, PH Weinreb, ... Hepatology 63 (1), 217-232, 2016 | 129 | 2016 |
| Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization LI Xu, ZW Peng, MS Chen, M Shi, YJ Zhang, RP Guo, XJ Lin, WY Lau Journal of hepatology 63 (1), 122-130, 2015 | 126 | 2015 |
| Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma LX Xu, MH He, ZH Dai, J Yu, JG Wang, XC Li, BB Jiang, ZF Ke, TH Su, ... Annals of Oncology 30 (6), 990-997, 2019 | 115 | 2019 |
| The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma R Lai, Z Peng, D Chen, X Wang, W Xing, W Zeng, M Chen Anesthesia & Analgesia 114 (2), 290-296, 2012 | 103 | 2012 |
| A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma ZW Peng, MS Chen, HH Liang, HJ Gao, YJ Zhang, JQ Li, YQ Zhang, ... European Journal of Surgical Oncology (EJSO) 36 (3), 257-263, 2010 | 97 | 2010 |
| Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results ZW Peng, YJ Zhang, MS Chen, XJ Lin, HH Liang, M Shi European Journal of Surgical Oncology 36 (11), 1054-1060, 2010 | 91 | 2010 |
| Insufficient radiofrequency ablation promotes hepatocellular carcinoma metastasis through N6‐methyladenosine mRNA methylation‐dependent mechanism T Su, M Huang, J Liao, S Lin, P Yu, J Yang, Y Cai, S Zhu, L Xu, Z Peng, ... Hepatology 74 (3), 1339-1356, 2021 | 90 | 2021 |
